Mesoblast Limited (MESO, MSB.AX) said that the U.S. Food and Drug Administration has granted its second generation allogeneic, ...
Mesoblast Ltd (ASX: MSB) shares are under pressure today despite some big news. What's going on with this share?
We appreciate FDA’s support in designating REVASCOR both RMAT and RPD status, a recognition of the potential impact of our therapy on the long-term adverse outcomes of these desperately ill children.
The biotech sector is fast emerging from its two-year funk amid a rush of news about clinical trials, approvals and ... Read ...
These shares are having a tough time on Thursday. What's going on? The post Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today appeared first on The Motley Fool ...